|

Pepcid (Famotidine) 20 mg q 12 hrs for 3 days Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • The University of Texas Health Science Center, Houston1

Indications

  • Heart Disease1
  • Acute Kidney Injury1

Houston, Texas1 trial

Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)

Memorial Hermann Texas Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.